<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01858285</url>
  </required_header>
  <id_info>
    <org_study_id>X10-04-0197</org_study_id>
    <nct_id>NCT01858285</nct_id>
  </id_info>
  <brief_title>Genetics of Severe Early Onset Epilepsies</brief_title>
  <official_title>Genetics of Epilepsy and Related Disorders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Children's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigators at Boston Children's Hospital are conducting research in order to better&#xD;
      understand the genetic factors which may contribute to disorders related to epilepsy. These&#xD;
      findings may help explain the broad spectrum of clinical characteristics and outcomes seen in&#xD;
      people with epilepsy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Many children with epilepsy experience seizures which respond well to treatment. A few types&#xD;
      of epilepsy, however, are characterized by seizures which begin very early in childhood and&#xD;
      are associated with severe intellectual and/or developmental disabilities. These conditions,&#xD;
      known as progressive epileptic encephalopathies, are particularly severe and are often&#xD;
      difficult to treat. These syndromes include infantile spasms, early infantile epileptic&#xD;
      encephalopathy with suppression bursts (Ohtahara syndrome), malignant migrating partial&#xD;
      epilepsy of infancy, early myoclonic epileptic encephalopathy, and severe myoclonic epilepsy&#xD;
      of infancy (Dravet syndrome).&#xD;
&#xD;
      The investigators' current research effort is focused on children with epileptic&#xD;
      encephalopathies, in particular Ohtahara syndrome. The investigators' goal is to identify&#xD;
      genetic alterations (known as &quot;mutations&quot;) that cause Ohtahara syndrome. By doing so the&#xD;
      investigators hope to improve diagnosis and treatment for this condition. It is also possible&#xD;
      that understanding the genetic basis of Ohtahara syndrome may in some instances make it&#xD;
      possible to prevent it from occurring in the future.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2010</start_date>
  <completion_date type="Anticipated">December 2030</completion_date>
  <primary_completion_date type="Anticipated">December 2030</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Identify new or existing causative mutations through whole exome sequencing of epilepsy patients</measure>
    <time_frame>10 years</time_frame>
    <description>Use whole exome sequencing to identify genetic mutations. Detailed clinical information will be collected via medical records and patient questionnaire, as well as biological parents' exome sequencing to classify mutations as causative or nonsignificant.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Epilepsy</condition>
  <condition>Epileptic Encephalopathy</condition>
  <condition>Ohtahara Syndrome</condition>
  <condition>Infantile Spasms</condition>
  <condition>Dravet Syndrome</condition>
  <condition>Malignant Migrating Partial Epilepsy of Infancy</condition>
  <condition>Early Myoclonic Epileptic Encephalopathy</condition>
  <condition>PCDH19-related Epilepsy and Related Conditions</condition>
  <arm_group>
    <arm_group_label>Epilepsy, genetics</arm_group_label>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      DNA from whole blood, saliva, or buccal swabs.&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Epilepsy&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Epilepsy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Annapurna Poduri, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Boston Children's Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Boston Children's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rebecca Pinsky</last_name>
      <phone>617-355-5254</phone>
      <email>epilepsygenetics@childrens.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>Annapurna Poduri, MD, MPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.childrenshospital.org/Centers-and-Services/Programs/A-_-E/epilepsy-genetics-program</url>
    <description>Epilepsy Genetics Program at Boston Children's Hospital website</description>
  </link>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>May 9, 2013</study_first_submitted>
  <study_first_submitted_qc>May 16, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 21, 2013</study_first_posted>
  <last_update_submitted>July 26, 2021</last_update_submitted>
  <last_update_submitted_qc>July 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Boston Children's Hospital</investigator_affiliation>
    <investigator_full_name>Annapurna Poduri</investigator_full_name>
    <investigator_title>Principle investigator Annapurna Poduri, MD, MPH, Boston Children's Hospital</investigator_title>
  </responsible_party>
  <keyword>Epilepsy</keyword>
  <keyword>Ohtahara</keyword>
  <keyword>Dravet</keyword>
  <keyword>MMPEI</keyword>
  <keyword>EMEE</keyword>
  <keyword>EIEE</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epilepsy</mesh_term>
    <mesh_term>Brain Diseases</mesh_term>
    <mesh_term>Epilepsies, Partial</mesh_term>
    <mesh_term>Epilepsies, Myoclonic</mesh_term>
    <mesh_term>Spasms, Infantile</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

